{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:38:17Z","timestamp":1722559097527},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,31]]},"DOI":"10.7759\/cureus.65901","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T05:23:02Z","timestamp":1722489782000},"source":"Crossref","is-referenced-by-count":0,"title":["Outcome of Primary Hyperparathyroidism: Retrospective Tertiary Center Experience From Basrah, Iraq"],"prefix":"10.7759","author":[{"given":"Suha M","family":"Abdul Khaleq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein  A","family":"Nwayyir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas A","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.104","article-title":"Primary hyperparathyroidism","volume":"14","author":"Walker MD","year":"2018","unstructured":"Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018, 14:115-25. 10.1038\/nrendo.2017.104","journal-title":"Nat Rev Endocrinol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad267","article-title":"Incidence of primary hyperparathyroidism in the current era: have we finally reached a steady state?","volume":"108","author":"Wermers RA","year":"2023","unstructured":"Wermers RA. Incidence of primary hyperparathyroidism in the current era: have we finally reached a steady state?. J Clin Endocrinol Metab. 2023, 108:e1749-50. 10.1210\/clinem\/dgad267","journal-title":"J Clin Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad201","article-title":"Stable incidence and increasing prevalence of primary hyperparathyroidism in a population-based study in Scotland","volume":"108","author":"Soto-Pedre E","year":"2023","unstructured":"Soto-Pedre E, Newey PJ, Leese GP. Stable incidence and increasing prevalence of primary hyperparathyroidism in a population-based study in Scotland. J Clin Endocrinol Metab. 2023, 108:e1117-24. 10.1210\/clinem\/dgad201","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.0538","article-title":"Diagnosis and management of primary hyperparathyroidism","volume":"323","author":"Zhu CY","year":"2020","unstructured":"Zhu CY, Sturgeon C, Yeh MW. Diagnosis and management of primary hyperparathyroidism. JAMA. 2020, 323:1186-7. 10.1001\/jama.2020.0538","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1772","article-title":"Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency","volume":"90","author":"Grey A","year":"2005","unstructured":"Grey A, Lucas J, Horne A, Gamble G, Davidson JS, Reid IR. Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J Clin Endocrinol Metab. 2005, 90:2122-6. 10.1210\/jc.2004-1772","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-017-4322-7","article-title":"Characteristics, management, and outcome of primary hyperparathyroidism at a single clinical center from 2005 to 2016","volume":"29","author":"Sun B","year":"2018","unstructured":"Sun B, Guo B, Wu B, Kang J, Deng X, Zhang Z, Fan Y. Characteristics, management, and outcome of primary hyperparathyroidism at a single clinical center from 2005 to 2016. Osteoporos Int. 2018, 29:635-42. 10.1007\/s00198-017-4322-7","journal-title":"Osteoporos Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism","volume":"151","author":"Wilhelm SM","year":"2016","unstructured":"Wilhelm SM, Wang TS, Ruan DT, et al.. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016, 151:959-68. 10.1001\/jamasurg.2016.2310","journal-title":"JAMA Surg"},{"key":"ref8","article-title":"Preoperative localization for parathyroid surgery in patients with primary hyperparathyroidism","author":"Yip L","year":"2024","unstructured":"Yip L, Silverberg S, Fuleihan GH, Rosen CJ. Preoperative localization for parathyroid surgery in patients with primary hyperparathyroidism. UpToDate. Post TW (ed): UpToDate, Waltham; 2024."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5603\/EP.a2020.0028","article-title":"Primary hyperparathyroidism","volume":"71","author":"Kowalski GJ","year":"2020","unstructured":"Kowalski GJ, Bu\u0142a G, \u017b\u0105d\u0142o D, Gawrychowska A, Gawrychowski J. Primary hyperparathyroidism. Endokrynol Pol. 2020, 71:260-70. 10.5603\/EP.a2020.0028","journal-title":"Endokrynol Pol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4670","article-title":"The Fifth International Workshop on the evaluation and management of primary hyperparathyroidism","volume":"37","author":"Bilezikian JP","year":"2022","unstructured":"Bilezikian JP, Khan AA, Clarke BL, Mannstadt M, Potts JT, Brandi ML. The Fifth International Workshop on the evaluation and management of primary hyperparathyroidism. J Bone Miner Res. 2022, 37:2290-2. 10.1002\/jbmr.4670","journal-title":"J Bone Miner Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-016-3514-1","article-title":"Outcomes of parathyroidectomy in patients with primary hyperparathyroidism: a systematic review and meta-analysis","volume":"40","author":"Singh Ospina NM","year":"2016","unstructured":"Singh Ospina NM, Rodriguez-Gutierrez R, Maraka S, et al.. Outcomes of parathyroidectomy in patients with primary hyperparathyroidism: a systematic review and meta-analysis. World J Surg. 2016, 40:2359-77. 10.1007\/s00268-016-3514-1","journal-title":"World J Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2022.09.042","article-title":"Comparative utility of preoperative imaging in normocalcemic versus hypercalcemic primary hyperparathyroidism","volume":"225","author":"Montgomery KB","year":"2023","unstructured":"Montgomery KB, Gillis A, Ramonell KM, Fazendin JM, Lindeman B, Chen H. Comparative utility of preoperative imaging in normocalcemic versus hypercalcemic primary hyperparathyroidism. Am J Surg. 2023, 225:293-7. 10.1016\/j.amjsurg.2022.09.042","journal-title":"Am J Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-022-01059-7","article-title":"Primary hyperparathyroidism in Saudi Arabia revisited: a multi-centre observational study","volume":"22","author":"Al-Saleh Y","year":"2022","unstructured":"Al-Saleh Y, AlSohaim A, AlAmoudi R, et al.. Primary hyperparathyroidism in Saudi Arabia revisited: a multi-centre observational study. BMC Endocr Disord. 2022, 22:155. 10.1186\/s12902-022-01059-7","journal-title":"BMC Endocr Disord"},{"key":"ref14","article-title":"Prevalence and incidence of primary hyperparathyroidism in Bahrain: a retrospective study from one medical center","volume":"42","author":"Abdulla J","year":"2021","unstructured":"Abdulla J, Suwaifi YM. Prevalence and incidence of primary hyperparathyroidism in Bahrain: a retrospective study from one medical center. Neuro Endocrinol Lett. 2021, 42:257-64.","journal-title":"Neuro Endocrinol Lett"},{"key":"ref15","article-title":"Clinical spectrum of primary hyperparathyroidism","volume":"24","author":"Younes NA","year":"2003","unstructured":"Younes NA, Al-Trawneh IS, Albesoul NM, Hamdan BR, Sroujieh AS. Clinical spectrum of primary hyperparathyroidism. Saudi Med J. 2003, 24:179-83.","journal-title":"Saudi Med J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.sopen.2021.02.002","article-title":"Monocentric experience of primary hyperparathyroidism surgery in Algeria","volume":"4","author":"Nouikes Zitouni S","year":"2021","unstructured":"Nouikes Zitouni S. Monocentric experience of primary hyperparathyroidism surgery in Algeria. Surg Open Sci. 2021, 4:32-6. 10.1016\/j.sopen.2021.02.002","journal-title":"Surg Open Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.14744\/SEMB.2021.72681","article-title":"Parathyroidectomy results in primary hyperparathyroidism: analysis of the results from a single center","volume":"55","author":"Unlu MT","year":"2021","unstructured":"Unlu MT, Aygun N, Akgun IE, Yetkin SG, Erol RS, Isgor A, Uludag M. Parathyroidectomy results in primary hyperparathyroidism: analysis of the results from a single center. Sisli Etfal Hastan Tip Bul. 2021, 55:173-8. 10.14744\/SEMB.2021.72681","journal-title":"Sisli Etfal Hastan Tip Bul"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1023\/a:1026508829397","article-title":"Clinical spectrum of primary hyperparathyroidism","volume":"1","author":"Bilezikian JP","year":"2000","unstructured":"Bilezikian JP, Silverberg SJ. Clinical spectrum of primary hyperparathyroidism. Rev Endocr Metab Disord. 2000, 1:237-45. 10.1023\/a:1026508829397","journal-title":"Rev Endocr Metab Disord"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-020-01142-w","article-title":"Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: data from PHPT registry","volume":"39","author":"Arya AK","year":"2021","unstructured":"Arya AK, Kumari P, Bhadada SK, et al.. Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: data from PHPT registry. J Bone Miner Metab. 2021, 39:253-9. 10.1007\/s00774-020-01142-w","journal-title":"J Bone Miner Metab"},{"key":"ref20","article-title":"Primary hyperparathyroidism in Saudi Arabia: a review of 46 cases","volume":"62","author":"Malabu UH","year":"2007","unstructured":"Malabu UH, Founda MA. Primary hyperparathyroidism in Saudi Arabia: a review of 46 cases. Med J Malaysia. 2007, 62:394-7.","journal-title":"Med J Malaysia"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.9738\/INTSURG-D-14-00094.1","article-title":"A 20-year study on 190 patients with primary hyperparathyroidism in a developing country: Turkey experience","volume":"100","author":"Usta A","year":"2015","unstructured":"Usta A, Alhan E, Cinel A, T\u00fcrky\u0131lmaz S, Erem C. A 20-year study on 190 patients with primary hyperparathyroidism in a developing country: Turkey experience. Int Surg. 2015, 100:648-55. 10.9738\/INTSURG-D-14-00094.1","journal-title":"Int Surg"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.190560","article-title":"Clinical and laboratory profile of primary hyperparathyroidism in Kashmir Valley: a single-center experience","volume":"20","author":"Misgar RA","year":"2016","unstructured":"Misgar RA, Dar PM, Masoodi SR, Ahmad M, Wani KA, Wani AI, Bashir MI. Clinical and laboratory profile of primary hyperparathyroidism in Kashmir Valley: a single-center experience. Indian J Endocrinol Metab. 2016, 20:696-701. 10.4103\/2230-8210.190560","journal-title":"Indian J Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/952426","article-title":"Primary hyperparathyroidism: 11-year experience in a single institute in Thailand","volume":"2012","author":"Prasarttong-Osoth P","year":"2012","unstructured":"Prasarttong-Osoth P, Wathanaoran P, Imruetaicharoenchoke W, Rojananin S. Primary hyperparathyroidism: 11-year experience in a single institute in Thailand. Int J Endocrinol. 2012, 2012:952426. 10.1155\/2012\/952426","journal-title":"Int J Endocrinol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.13005\/bpj\/2317","article-title":"Total vitamin D3 (25-hydroxyvitamin D) concentrations in Basrah, Iraq","volume":"14","author":"Hussein IH","year":"2021","unstructured":"Hussein IH, Mansour AA, Nwayyir HA, et al.. Total vitamin D3 (25-hydroxyvitamin D) concentrations in Basrah, Iraq. Biomed Pharmacol J. 2021, 14:2191-8. 10.13005\/bpj\/2317","journal-title":"Biomed Pharmacol J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4103\/jhnps.jhnps_29_16","article-title":"Clinical presentation and outcome of surgical management of primary hyperparathyroidism: a single center-based case series in Egypt","volume":"5","author":"Mahmoud HG","year":"2017","unstructured":"Mahmoud HG. Clinical presentation and outcome of surgical management of primary hyperparathyroidism: a single center-based case series in Egypt. J Head Neck Physicians Surg. 2017, 5:17-22. 10.4103\/jhnps.jhnps_29_16","journal-title":"J Head Neck Physicians Surg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.14744\/SEMB.2023.39260","article-title":"Persistent and recurrent primary hyperparathyroidism: etiological factors and pre-operative evaluation","volume":"57","author":"Uludag M","year":"2023","unstructured":"Uludag M, Unlu MT, Kostek M, Caliskan O, Aygun N, Isgor A. Persistent and recurrent primary hyperparathyroidism: etiological factors and pre-operative evaluation. Sisli Etfal Hastan Tip Bul. 2023, 57:1-17. 10.14744\/SEMB.2023.39260","journal-title":"Sisli Etfal Hastan Tip Bul"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/279643-outcome-of-primary-hyperparathyroidism-retrospective-tertiary-center-experience-from-basrah-iraq","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T05:23:07Z","timestamp":1722489787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/279643-outcome-of-primary-hyperparathyroidism-retrospective-tertiary-center-experience-from-basrah-iraq"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.65901","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,31]]}}}